The significance of CHEK2 variants in cancer risk assessment
The Medical News,
A new editorial was published in Oncotarget's Volume 15 on July 10, 2024, entitled, "Genotype matters: Personalized screening…
Editorial: Genotype matters—tailored screening for germline CHEK2 variants
MedicalXpress,
A recent editorial was published in Oncotarget, titled "Genotype matters: Personalized screening recommendations for germline…
Genotype Matters: Tailored screening for germline CHEK2 variants
Bioengineer.org,
“In our study, we postulated that these differences were driven by three common low-risk (LR) missense variants: p.I157T, p.S428F…